Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA (“HBC”) has today, 17 September 2026, bought 2,500,000 shares in HBC in an off-market transaction at an average price of NOK 1.13 per share.
After the transaction, Mr. Baldegger holds 8,824,899 shares in HBC, equal to approximately 1.86 % of the total outstanding A-shares with voting rights.
For further information, contact:
Jon Olav Ødegård, CEO of Hofseth BioCare ASA
Phone: +47 936 32 966 E-mail: joo@hofsethbiocare.no
This information is subject to the disclosure requirements in the Market Abuse Regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.
Attachment
